gsk.com - Aset Bersih saben Siji Saham GSK

GSK plc (GSK) is a defensive asset characterized by an autumn peak in vaccine sales and immunity to crises. The net asset value per share visualizes this resilience, where the 11.67 metric determines this level. A strong team of immunologists within the British environment guarantees the quality of development, while effective margin scaling despite high R&D costs drives current profitability.

Nilai Akuntansi Saham: GSK Corp (GSK) kanggo 04.07.2022 - 27.10.2026

GlaxoSmithKline plc - rincian analitis lan metrik utama (GSK)

- rega lan prakiraan konsensus rega:

Bagan rega GSK Corp|GSK - Prakiraan konsensus analis

- data kapitalisasi pasar:

Nilai pasar GlaxoSmithKline|GSK - Nilai Wutuh Bisnis

- data kapitalisasi buku:

Nilai Buku saben Saham GSK|GSK - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku gsk.com|GSK - Total Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas GSK plc|GSK - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas GSK Corp|GSK - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku GlaxoSmithKline

Analisis kabeh metrik perusahaan:gsk.com (GSK)

To minimize fundamental risks, investors opt for assets with stable capital. This indicator is calculated as the difference between all assets and liabilities of GSK plc (GSK), divided by the number of shares. For a pharmaceutical behemoth with an advanced R&D pipeline and a mature vaccine portfolio, this metric reflects the real value of the tangible asset base. The price action for the fair book value per share confirms the defensive qualities of the business.

Analisis pesaing